|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
140,990,000 |
Market
Cap: |
73.88(M) |
Last
Volume: |
2,041,307 |
Avg
Vol: |
1,748,484 |
52
Week Range: |
$0.2971 - $1.74 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sangamo BioSciences is a clinical-stage genomic medicine company focused on translating science into medicines. Co.'s clinical-stage product candidates are: Isaralgagene civaparvovec (ST-920), which is Co.'s wholly-owned gene therapy product candidate for the treatment of Fabry disease; SAR445136, which is Co.'s zinc finger nuclease gene-edited cell therapy product candidate for the treatment of sickle cell disease; TX200 for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and Giroctocogene fitelparvovec (SB-525), which is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
6,000,000 |
6,000,000 |
Total Sell Value |
$0 |
$0 |
$3,000,000 |
$3,000,000 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-12-08 |
4 |
D |
$16.90 |
$39,681 |
D/D |
(2,348) |
13,485 |
|
- |
|
Conner Edward R. |
Sr. VP & Chief Medical Officer |
|
2017-12-06 |
4 |
AS |
$16.24 |
$81,200 |
D/D |
(5,000) |
0 |
|
- |
|
Conner Edward R. |
Sr. VP & Chief Medical Officer |
|
2017-12-06 |
4 |
OE |
$3.20 |
$16,000 |
D/D |
5,000 |
5,000 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-12-04 |
4 |
AS |
$18.00 |
$212,454 |
D/D |
(11,803) |
15,833 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-12-04 |
4 |
OE |
$12.12 |
$143,052 |
D/D |
11,803 |
27,636 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-12-01 |
4 |
AS |
$16.70 |
$53,390 |
D/D |
(3,197) |
15,833 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-12-01 |
4 |
OE |
$8.87 |
$11,039 |
D/D |
1,197 |
19,030 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-11-30 |
4 |
AS |
$16.00 |
$214,928 |
D/D |
(13,433) |
17,833 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-11-30 |
4 |
OE |
$9.41 |
$126,405 |
D/D |
13,433 |
31,266 |
|
- |
|
Ramasastry Saira |
Director |
|
2017-11-17 |
4 |
S |
$14.67 |
$73,339 |
D/D |
(5,000) |
0 |
|
- |
|
Ramasastry Saira |
Director |
|
2017-11-17 |
4 |
OE |
$5.03 |
$25,150 |
D/D |
5,000 |
5,000 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-10-02 |
4 |
AS |
$15.00 |
$228,754 |
D/D |
(15,000) |
15,833 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-10-02 |
4 |
OE |
$5.41 |
$114,905 |
D/D |
15,000 |
19,587 |
|
- |
|
Ringo William R |
Director |
|
2017-09-20 |
4 |
S |
$14.37 |
$445,597 |
D/D |
(31,000) |
800 |
|
- |
|
Ringo William R |
Director |
|
2017-09-20 |
4 |
OE |
$6.05 |
$187,550 |
D/D |
31,000 |
31,800 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-09-01 |
4 |
AS |
$15.00 |
$225,000 |
D/D |
(15,000) |
15,833 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-09-01 |
4 |
OE |
$5.41 |
$55,810 |
D/D |
10,316 |
26,149 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-08-14 |
4 |
AS |
$11.00 |
$55,000 |
D/D |
(5,000) |
20,517 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-08-14 |
4 |
OE |
$5.12 |
$25,600 |
D/D |
5,000 |
25,517 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-08-11 |
4 |
AS |
$10.00 |
$64,740 |
D/D |
(6,474) |
20,517 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-08-11 |
4 |
OE |
$2.55 |
$21,511 |
D/D |
6,474 |
26,991 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-07-14 |
4 |
AS |
$10.00 |
$150,000 |
D/D |
(15,000) |
20,517 |
|
- |
|
Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
|
2017-07-14 |
4 |
OE |
$3.99 |
$686 |
D/D |
172 |
35,517 |
|
- |
|
Herberts Curt A. Iii |
Senior VP & CBO |
|
2017-06-01 |
4 |
AS |
$6.80 |
$13,600 |
D/D |
(2,000) |
35,345 |
|
- |
|
Herberts Curt A. Iii |
Senior VP & CBO |
|
2017-05-12 |
4 |
AS |
$8.50 |
$17,000 |
D/D |
(2,000) |
37,345 |
|
- |
|
548 Records found
|
|
Page 13 of 22 |
|
|